HighTower Advisors’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25,144
| Closed | -$147K | – | 4049 |
|
|
2025
Q1 | $147K | Buy |
+25,144
| New | +$132K | ﹤0.01% | 3275 |
|
|
2024
Q3 | – | Sell |
-10,006
| Closed | -$83K | – | 4027 |
|
|
2024
Q2 | $83K | Buy |
+10,006
| New | +$107K | ﹤0.01% | 3242 |
|
|
2024
Q1 | – | Sell |
-9,535
| Closed | -$204K | – | 4080 |
|
|
2023
Q4 | $204K | Sell |
9,535
-1,332
| -12% | -$23.8K | ﹤0.01% | 2997 |
|
|
2023
Q3 | $208K | Sell |
10,867
-3,210
| -23% | -$68.5K | ﹤0.01% | 2885 |
|
|
2023
Q2 | $359K | Buy |
14,077
+152
| +1% | +$4.39K | ﹤0.01% | 2430 |
|
|
2023
Q1 | $502K | Buy |
13,925
+149
| +1% | +$5.23K | ﹤0.01% | 2105 |
|
|
2022
Q4 | $545K | Sell |
13,776
-4,479
| -25% | -$186K | ﹤0.01% | 2074 |
|
|
2022
Q3 | $851K | Buy |
18,255
+504
| +3% | +$23.4K | ﹤0.01% | 1703 |
|
|
2022
Q2 | $779K | Buy |
17,751
+122
| +0.7% | +$6.71K | ﹤0.01% | 1783 |
|
|
2022
Q1 | $1.27M | Buy |
17,629
+2,391
| +16% | +$172K | ﹤0.01% | 1616 |
|
|
2021
Q4 | $1.24M | Buy |
15,238
+4,859
| +47% | +$487K | ﹤0.01% | 1651 |
|
|
2021
Q3 | $1.21M | Buy |
10,379
+100
| +1% | +$13.1K | ﹤0.01% | 1552 |
|
|
2021
Q2 | $1.7M | Sell |
10,279
-50
| -0.5% | -$7.8K | ﹤0.01% | 1317 |
|
|
2021
Q1 | $1.44M | Sell |
10,329
-4,440
| -30% | -$724K | ﹤0.01% | 1341 |
|
|
2020
Q4 | $2.56M | Sell |
14,769
-860
| -6% | -$139K | 0.01% | 807 |
|
|
2020
Q3 | $2.18M | Buy |
15,629
+2,716
| +21% | +$363K | 0.01% | 846 |
|
|
2020
Q2 | $1.54M | Sell |
12,913
-5,875
| -31% | -$697K | 0.01% | 911 |
|
|
2020
Q1 | $1.88M | Buy |
18,788
+3,555
| +23% | +$428K | 0.01% | 770 |
|
|
2019
Q4 | $1.79M | Buy |
15,233
+1,650
| +12% | +$163K | 0.01% | 900 |
|
|
2019
Q3 | $1.17M | Buy |
13,583
+4,525
| +50% | +$342K | 0.01% | 1103 |
|
|
2019
Q2 | $587K | Buy |
+9,058
| New | +$564K | ﹤0.01% | 1439 |
|
Other funds holding NVRO
HighTower Advisors's NVRO Position: Q2 2025 in Review
HighTower Advisors sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 25,144 shares — an estimated $147K sold.
HighTower Advisors first reported a position in NVRO in Q2 2019 and held it in 21 quarters. The position peaked at $2.56M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- HighTower Advisors reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- HighTower Advisors sold 25,144 NEVRO CORP. shares in Q2 2025, an estimated $147K.
- HighTower Advisors first reported a position in NEVRO CORP. in Q2 2019 and held it in 21 quarters.
- HighTower Advisors's NEVRO CORP. position peaked at $2.56M in Q4 2020.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on HighTower Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.